Stoeck M, Miescher S, MacDonald H R, Von Fliedner V
Ludwig Institute for Cancer Research, Epalinges, Switzerland.
J Cell Physiol. 1989 Oct;141(1):65-73. doi: 10.1002/jcp.1041410111.
Transforming growth factors beta (TGF-beta) inhibit the growth of a variety of cell types, including lymphocytes. The immunosuppressive effects of TGF-beta have been attributed to the interference of these molecules with the interleukin-2 (IL-2)-driven component of lymphocyte proliferation. In order to elucidate in more detail the effects of TGF-beta on IL-2-induced proliferation, we investigated the effects of porcine transforming growth factor beta 1 and 2 (pTGF-beta 1 and 2) on the IL-2-driven proliferation of a murine IL-2-dependent T-lymphocyte line (CTLL). The results showed that pTGF-beta 1 and 2 decreased 3H-thymidine incorporation in CTLL cells in a dose-dependent fashion (maximum decrease of 75-85%). Combined-time kinetic analysis of the effects of pTGF-beta on 3H-thymidine incorporation, cell growth, and cell-cycle distribution (monitored as DNA content distribution) revealed that, in the first 48 h of culture, pTGF-beta 1 increased the doubling time from 11.4 to 19.2 h without significantly affecting the cell-cycle distribution of CTLL cells. After 96 h of culture in the presence of pTGF-beta 1, cells started to accumulate in G0/G1, although at this time point 30% of the pTGF-beta 1-treated cells were still in S-G2/M. Furthermore, during the first 48 h, neither the expression of the 55 kd chain of the IL-2 receptor (IL-2R) nor the expression of the transferrin receptor (TfR) was affected by TGF-beta. After 72 h of culture in the presence of pTGF-beta 1, the expression of the IL-2R and TfR was decreased. The data suggest that in CTLL cells TGF-beta initially slows the progression of cells in all phases of cell cycle. In addition, the initial TGF-beta-mediated decrease of IL-2-induced 3H-thymidine incorporation and cell proliferation in CTLL cells is not due primarily to downregulation of the IL-2R and/or TfR.
转化生长因子β(TGF-β)可抑制多种细胞类型的生长,包括淋巴细胞。TGF-β的免疫抑制作用归因于这些分子对白介素-2(IL-2)驱动的淋巴细胞增殖成分的干扰。为了更详细地阐明TGF-β对IL-2诱导的增殖的影响,我们研究了猪转化生长因子β1和2(pTGF-β1和2)对小鼠IL-2依赖性T淋巴细胞系(CTLL)的IL-2驱动增殖的影响。结果表明,pTGF-β1和2以剂量依赖性方式降低了CTLL细胞中3H-胸腺嘧啶核苷的掺入(最大降低75-85%)。对pTGF-β对3H-胸腺嘧啶核苷掺入、细胞生长和细胞周期分布(以DNA含量分布监测)的影响进行的联合时间动力学分析表明,在培养的最初48小时内,pTGF-β1使倍增时间从11.4小时增加到19.2小时,而对CTLL细胞的细胞周期分布没有显著影响。在pTGF-β1存在下培养96小时后,细胞开始在G0/G1期积累,尽管此时30%的pTGF-β1处理细胞仍处于S-G2/M期。此外,在最初的48小时内,TGF-β既不影响IL-2受体(IL-2R)55 kd链的表达,也不影响转铁蛋白受体(TfR)的表达。在pTGF-β1存在下培养72小时后,IL-2R和TfR的表达降低。数据表明,在CTLL细胞中,TGF-β最初会减缓细胞周期各阶段细胞的进程。此外,CTLL细胞中最初由TGF-β介导的IL-2诱导的3H-胸腺嘧啶核苷掺入和细胞增殖的降低并非主要由于IL-2R和/或TfR的下调。